CoChat

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis

Open access
Nemeth, Elizabeta, Ganz, Tomas · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.

Abstract

Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.

Overview

CoChat Summary

TL;DR

The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.

Key findings

  • Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
  • Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
  • The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
  • Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.

Methods

  • Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
  • The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
  • Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.

Limitations

  • The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
  • Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
  • Not stated in the paper: an explicit limitations section or discussion of publication bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms22126493

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The key iron flows and compartments.
Figure 1 The key iron flows and compartments.CC BY · PubMed Central
Figure 2 The interaction of hepcidin with ferroportin controls iron flows into plasma.
Figure 2 The interaction of hepcidin with ferroportin controls iron flows into plasma.CC BY · PubMed Central
Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].
Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].CC BY · PubMed Central
Figure 4 Iron, erythropoiesis and inflammation regulate hepcidin transcription through their effects on hepatocytes and by modulating the paracrine signaling between hepatic sinusoidal endothelium and hepatocytes.
Figure 4 Iron, erythropoiesis and inflammation regulate hepcidin transcription through their effects on hepatocytes and by modulating the paracrine signaling between hepatic sinusoidal endothelium and hepatocytes.CC BY · PubMed Central
Figure 5 Although ferroportin is evolutionarily ancient, the thiol cysteine required for hepcidin binding by ferroportin appears first in early vertebrate ferroportins. Cartilaginous fish ferroportin that contains the C326-equivalent is denoted with species name in red. Second ferroportin in cartilaginous fish that has another amino acid in this position is denoted with species name in blue. Invertebrate ferroportin lacks C326 and is denoted with species name in black.
Figure 5 Although ferroportin is evolutionarily ancient, the thiol cysteine required for hepcidin binding by ferroportin appears first in early vertebrate ferroportins. Cartilaginous fish ferroportin that contains the C326-equivalent is denoted with species name in red. Second ferroportin in cartilaginous fish that has another amino acid in this position is denoted with species name in blue. Invertebrate ferroportin lacks C326 and is denoted with species name in black.CC BY · PubMed Central

Verification

Claims the paper makes

31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations

44 more claims · 19 with their cited sources checked

Create a free account to see all 82 claims and to verify the 10 references still open.

See all claims — free account
  • It may state two separate claims as one. 31
  • Probably not a substantial claim. 3
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 540

Metadata

Authors
Nemeth, E., & Ganz, T.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Ganz, Tomas
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-17
Volume
22
Issue
12
Pages
6493
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3172506357
Cited by
540
References
69
Citations by year
2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
FWCI
12.91
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
MeSH terms
Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.